Article

Screenwriters know there is a magic formula called “structure” that must be adhered to when writing a successful script. A key element is what occurs at the nine-minute mark in a film. That’s when the hero’s life undergoes a change that forces them to take action and regain their footing, which catalyzes the triumphant conclusion.

Problem: A variety of factors can result in obsolete laboratory equipment and R&D devices. Project
completion, equipment upgrade, lab closure, and downsizing all create surplus pharmaceutical assets
no longer required in the same capacity—or at all. Given budget restrictions and the importance placed
on environmentally-sound business practices, organizations can’t afford to allow surplus assets to lie
idle or dispose of them without thought to the process. Surplus requires an innovative and sustainable
process that supports strategic business goals.

Problem: The human genome encodes thousands of secreted proteins, each of which is an actor in
the delicate biochemical balance of diagnostics. Even a slight change in any one of these proteins can
mean the difference between sickness and health. Such a change also provides a critical window into
the body and helps to direct diagnosis and treatment, however, the vast majority of secreted proteins
are present in concentrations well below what conventional technologies can measure, and their role in
human health is poorly understood.

Dr. Anne Carpenter leads the Imaging Platform at the Broad Institute of Harvard and MIT—a team of biologists and computer scientists who develop image analysis and data mining methods and software that are freely available to the public through the open-source CellProfiler project.
Dr. Arvind Rao has been an assistant professor in the Department of Bioinformatics and Computational Biology at the University of Texas MD Anderson Cancer Center since 2011.

Like great athletes and musicians, cells employed in cell-based assays or as expression systems for biopharmaceutical production are not born, but made. Cell lines that perform specifically and predictably arise from a population of cells that have undergone one or more genetic transformations (transfection) and are subsequently selected for desirable properties such as viability, protein or virus production; high culture density; or binding to drugs or antigens.

You are the manager of a big company and you know your business. Each day, you make important decisions regarding money, policy and strategy. You’re in total control. Without warning, you are confronted with a major crisis: an earthquake, a fire or a reputational risk. Now you find yourself uncertain and unsure. You don’t know what to do and you realize that everybody is looking to you for guidance—and the decision you are about to make will directly affect the survival of your company.

With headlines screaming about hacking, of the latest James Bond movie Skyfall most recently, of national and nuclear weapons laboratories not so long ago, and of businesses and individuals almost on a daily basis, it’s no surprise that worldwide information technology (IT) security spending is set to hit $77 billion in 2015—almost 8 percent more than this year’s $71 billion, according to IT researcher Gartner, Inc.

In the last issue of Lab Manager, we began to explore the ergonomic risk factors associated with the use of
computers. To recap briefly, three of the fundamental ergonomic risk factors are: position/posture, repetition/duration, and force. These can all be influenced by the work area setup and the activities being performed.











